Sepsis Diagnostics Market Forecast, Business Strategy and Key Vendors 2027

1
Sepsis Diagnostics Market Analysis, Regional
Outlook, Business Landscape 2027

• Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Sepsis Diagnostics Market Forecast to 2028 -
  COVID-19 Impact and Global Analysis By Product
  (Instruments, Reagents and Assays, Blood Culture
  Media, and Software), Technology Molecular
  Diagnostics (Polymerase Chain Reaction, Peptide
  Nucleic Acid-Fluorescent in Situ Hybridization,
  Syndromic Panel-Based Testing, and Microarray),
  Flow Cytometry, Microfluidics, Immunoassay,
  Biomarker, and Microbiology, Method (Automated
  Diagnostics and Conventional Diagnostics), Test
  Type (Point-of-Care Tests and Laboratory Tests),
  Pathogen (Bacterial Sepsis, Fungal Sepsis, and
  Others), and End User (Hospitals, Pathology and
  Reference Laboratories, and Others)

3
Sepsis Diagnostics Market Overview
Email sales_at_theinsightpartners.com

• The Sepsis Diagnostics Market is projected to
  reach US 1,226.52 million by 2028 from US
  661.83 million in 2021 it is expected to grow at
  a CAGR of 9.2 from 2021 to 2028.
• The sepsis diagnostics market growth is
  attributed to the high incidence of sepsis due to
  increasing nosocomial infections and rise in
  demand for rapid diagnostic tests leading to
  increasing product launches. However, the lack of
  skilled professionals hampers the market growth.
  Infection is the root cause of sepsis. Sepsis
  mainly occurs in immunocompromised people, such
  as those taking chemotherapy, having a
  splenectomy, and suffering from AIDS and chronic
  illnesses like diabetes. Among several types of
  infections, nosocomial infections are the primary
  cause of morbidity and mortality among
  hospitalized patients.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Product (Instrument, Reagent And Assay, Blood
  Culture Media, And Software.)
• By Technology (Molecular Diagnostics, Flow
  Cytometry, Microfluidics, Immunoassay,
  Biomarkers, And Microbiology)
• End-User (Hospitals, Pathology And Reference
  Laboratories, And Others.)

Download Sample
5
Sepsis Diagnostics Market Value
Email sales_at_theinsightpartners.com

• CAGR of 9.2
• (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Abbott
• F. HOFFMANN-LA ROCHE LTD.
• Immunexpress Inc.
• BD
• Danaher
• Luminex Corporation
• Thermo Fisher Scientific Inc.
• bioMerieux SA.
• T2 Biosystems, Inc.
• Axis-Shield Diagnostics Ltd.

Download Sample
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com